Membrane Oxygenator Market (By Type: Hollow Fibre Membrane Oxygenator and Flat Sheet Membrane Oxygenator; By Application: Respiratory, Cardiac, and Extra-Corporeal Cardiopulmonary Resuscitation (ECPR); By Region: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
The global membrane oxygenator market was valued at USD 352 million in 2024 and is projected to reach approximately USD 496.53 million by 2034, growing at a CAGR of 3.5%. The market growth is primarily driven by the rising prevalence of cardiovascular diseases, increasing adoption of extracorporeal membrane oxygenation (ECMO) procedures, and continuous technological advancements in oxygenator design.
Reports Attributes | Statistics |
Market Size in 2024 | USD 352 Million |
Market Size in 2025 | USD 364.32 Million |
Market Size in 2031 | USD 447.84 Million |
Market Size by 2034 | USD 496.53 Million |
CAGR 2025 to 2034 | 3.5% |
Base Year | 2024 |
Forecast Period | 2025 to 2034 |
The membrane oxygenator market is attaining significant popularity due to the rising cardiovascular and respiratory disease burden, which creates a massive demand for such medical devices. WHO also states that the prevalence of CVD is around 80% in low and middle-income countries due to limited healthcare service options. This is mainly due to the higher treatment costs and poor healthcare infrastructure in these regions, which may hinder the growth pace of the market. However, the governments in the developing economies are trying to invest more in their healthcare infrastructure to enable services to their citizens. They are also targeting domestic manufacturing of such medical devices to increase their affordability in their own regions.
The emergence of technologies like Artificial Intelligence (AI) and Machine Learning (ML) is playing a transformative role in the membrane oxygenator market due to their algorithms that track the oxygen levels, blood flow, and other parameters during diagnosis. Moreover, they are also helping in personalizing treatment options based on past data for more accurate outcomes.
Published by Kesiya Chacko
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Hollow Fibre Membrane Oxygenator | 299.20 | 310.22 | 321.64 | 333.49 | 345.76 | 358.50 | 371.69 | 385.37 | 399.55 | 414.26 | 429.50 |
Flat Sheet Membrane Oxygenator | 52.80 | 54.10 | 55.43 | 56.78 | 58.17 | 59.57 | 61.01 | 62.47 | 63.97 | 65.48 | 67.03 |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Respiratory | 133.76 | 138.08 | 142.53 | 147.13 | 151.88 | 156.78 | 161.83 | 167.04 | 172.43 | 177.98 | 183.72 |
Cardiac | 197.12 | 202.20 | 207.39 | 212.70 | 218.12 | 223.67 | 229.33 | 235.12 | 241.03 | 247.07 | 253.23 |
Extra-Corporeal Cardiopulmonary Resuscitation (ECPR) | 21.12 | 24.04 | 27.15 | 30.44 | 33.93 | 37.62 | 41.54 | 45.68 | 50.06 | 54.69 | 59.58 |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
North America | 119.68 | 122.78 | 125.94 | 129.18 | 132.49 | 135.87 | 139.33 | 142.86 | 146.47 | 150.16 | 153.92 |
Asia Pacific | 98.56 | 103.47 | 108.60 | 113.96 | 119.56 | 125.42 | 131.54 | 137.93 | 144.62 | 151.60 | 158.89 |
Europe | 105.60 | 108.57 | 111.61 | 114.74 | 117.95 | 121.24 | 124.62 | 128.08 | 131.64 | 135.29 | 139.03 |
LAMEA | 28.16 | 29.50 | 30.92 | 32.39 | 33.93 | 35.54 | 37.21 | 38.97 | 40.79 | 42.69 | 44.69 |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Hollow Fibre Membrane Oxygenator | 299.20 | 310.22 | 321.64 | 333.49 | 345.76 | 358.50 | 371.69 | 385.37 | 399.55 | 414.26 | 429.50 |
Flat Sheet Membrane Oxygenator | 52.80 | 54.10 | 55.43 | 56.78 | 58.17 | 59.57 | 61.01 | 62.47 | 63.97 | 65.48 | 67.03 |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Respiratory | 133.76 | 138.08 | 142.53 | 147.13 | 151.88 | 156.78 | 161.83 | 167.04 | 172.43 | 177.98 | 183.72 |
Cardiac | 197.12 | 202.20 | 207.39 | 212.70 | 218.12 | 223.67 | 229.33 | 235.12 | 241.03 | 247.07 | 253.23 |
Extra-Corporeal Cardiopulmonary Resuscitation (ECPR) | 21.12 | 24.04 | 27.15 | 30.44 | 33.93 | 37.62 | 41.54 | 45.68 | 50.06 | 54.69 | 59.58 |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
North America | 119.68 | 122.78 | 125.94 | 129.18 | 132.49 | 135.87 | 139.33 | 142.86 | 146.47 | 150.16 | 153.92 |
Asia Pacific | 98.56 | 103.47 | 108.60 | 113.96 | 119.56 | 125.42 | 131.54 | 137.93 | 144.62 | 151.60 | 158.89 |
Europe | 105.60 | 108.57 | 111.61 | 114.74 | 117.95 | 121.24 | 124.62 | 128.08 | 131.64 | 135.29 | 139.03 |
LAMEA | 28.16 | 29.50 | 30.92 | 32.39 | 33.93 | 35.54 | 37.21 | 38.97 | 40.79 | 42.69 | 44.69 |
To get full access to our Market Insights, you need a Professional Account or a Business Suite.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Our customers work more efficiently and benefit from